Therapy of candidosis vulvovaginitis at pregnancy

Cover Page


Cite item

Full Text

Abstract

Clinical effectiveness gyno-pevaryl (GP) is investigated at treatment acute (30 women) and chronic (38 patients) candidosis vulvovaginitis in the period of pregnancy. In an end of course of treatment GP clinical and laboratory the confirmed recovery is marked in the first group at 80.0 % patients, in the second and the third - at 76.3 % patients. Gynopevaryl is an effective preparation for local treatment acute and chronic candidosis vulvovaginitis.

About the authors

I. A. Simchera

Military Medical Academy; Research Institute of Military Medicine, Ministry of Defense of the Russian Federation

Author for correspondence.
Email: info@eco-vector.com
Russian Federation, St. Petersburg; St. Petersburg

E. F. Kira

Military Medical Academy; Research Institute of Military Medicine, Ministry of Defense of the Russian Federation

Email: info@eco-vector.com
Russian Federation, St. Petersburg; St. Petersburg

V. M. Dobrynin

Military Medical Academy; Research Institute of Military Medicine, Ministry of Defense of the Russian Federation

Email: info@eco-vector.com
Russian Federation, St. Petersburg; St. Petersburg

References

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Results of treatment of vaginal candidiasis in pregnant women.

Download (3MB)

Copyright (c) 1998 Eсо-Vector



Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).